Enhanced dissolution and bioavailability of revaprazan using self-nanoemulsifying drug delivery system.

Goo, Yoon Tae; Sa, Cheol-Ki; Kim, Min Song; Sin, Gi Hyeong; Kim, Chang Hyun; Kim, Hyeon Kyun; Kang, Myung Joo; Lee, Sangkil; Choi, Young Wook

Goo, Yoon Tae; Sa, Cheol-Ki; Kim, Min Song; Sin, Gi Hyeong; Kim, Chang Hyun; Kim, Hyeon Kyun; Kang, Myung Joo; Lee, Sangkil; Choi, Young Wook.

Afiliação

Goo YT; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Sa CK; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Kim MS; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Sin GH; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Kim CH; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Kim HK; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.
Kang MJ; College of Pharmacy, Dankook University, Cheonan, Republic of Korea.
Lee S; College of Pharmacy, Keimyung University, Daegu, Republic of Korea.
Choi YW; College of Pharmacy, Chung-Ang University, Seoul, Republic of Korea.

Pharm Dev Technol ; 27(4): 414-424, 2022 Apr.

Article em En | MEDLINE | ID: mdl-35467467

Assuntos

Nanopartículas; Administração Oral; Animais; Disponibilidade Biológica; Sistemas de Liberação de Medicamentos/métodos; Liberação Controlada de Fármacos; Emulsões; Tamanho da Partícula; Pirimidinonas; Ratos; Solubilidade; Tetra-Hidroisoquinolinas

Palavras-chave

Self-nanoemulsifying drug delivery system; cycloheximide; lymphatic transport; oral bioavailability; revaprazan

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Nanopartículas Limite: Animals Idioma: En Revista: Pharm Dev Technol Assunto da revista: FARMACIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google